REPLAGAL Trademark

Trademark Overview

On Sunday, October 15, 2006, a trademark application was filed for REPLAGAL with the United States Patent and Trademark Office. The USPTO has given the REPLAGAL trademark a serial number of 77021430. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, September 7, 2017. This trademark is owned by Shire Human Genetic Therapies, Inc.. The REPLAGAL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of enzyme deficiencies; Pharmaceutical preparations for the treatment of Fabry disease
replagal

General Information

Serial Number77021430
Word MarkREPLAGAL
Filing DateSunday, October 15, 2006
Status800 - REGISTERED AND RENEWED
Status DateThursday, September 7, 2017
Registration Number3273816
Registration DateTuesday, August 7, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 22, 2007

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of enzyme deficiencies; Pharmaceutical preparations for the treatment of Fabry disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 19, 2006
Primary Code005
First Use Anywhere DateThursday, February 12, 2004
First Use In Commerce DateThursday, February 12, 2004

Trademark Owner History

Party NameShire Human Genetic Therapies, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameShire Human Genetic Therapies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameShire Human Genetic Therapies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Wednesday, July 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 1, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 1, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, September 7, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, September 7, 2017REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, September 7, 2017REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, September 6, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, July 26, 2017TEAS SECTION 8 & 9 RECEIVED
Wednesday, July 26, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, August 7, 2016COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, August 20, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, August 20, 2013REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, August 2, 2013REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Tuesday, August 20, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, August 2, 2013TEAS SECTION 8 & 15 RECEIVED
Thursday, June 30, 2011APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 30, 2011TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 8, 2009APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 8, 2009TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 7, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, May 22, 2007PUBLISHED FOR OPPOSITION
Wednesday, May 2, 2007NOTICE OF PUBLICATION
Tuesday, March 27, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 27, 2007ASSIGNED TO LIE
Friday, March 2, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 2, 2007EXAMINER'S AMENDMENT ENTERED
Friday, March 2, 2007EXAMINERS AMENDMENT E-MAILED
Friday, March 2, 2007EXAMINERS AMENDMENT -WRITTEN
Thursday, March 1, 2007ASSIGNED TO EXAMINER
Thursday, October 19, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

replagal pharmaceutical treatment preparations disease fabry enzyme deficiencies